Sale by Kathleen Cronin of 4960 shares of CME
| By Kathleen Cronin | Macroaxis Story |
Filed transaction by Cme Group Inc officer. General open market or private sale of non-derivative or derivative security
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Transaction by Kathleen Cronin
How important is CME's Liquidity
CME financial leverage refers to using borrowed capital as a funding source to finance CME Group ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. CME financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to CME's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of CME's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between CME's total debt and its cash.
CME Gross Profit
CME Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing CME previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show CME Gross Profit growth over the last 10 years. Please check CME's gross profit and other fundamental indicators for more details.
Breaking it down
CME Group insider trading alert for sale of common stock class a by Kathleen Cronin, Sr MD Gen Counsel & Corp Secr, on May 21, 2019. This event was filed by Cme Group Inc with SEC on 2019-05-22. Statement of changes in beneficial ownership - SEC Form 4. Kathleen Cronin is currently serves as senior managing director, general counsel, corporate secretary of CME Group
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio Architect